NFATc1 can also be activated by the B cell receptor (BCR) and upregulate the IL-10 chemokine to activate the JAK2/STAT3 pathway in B cell lymphoma cells, ultimately inducing PD-L1 expression [42]. Here, NFATC1 is linked to B-cell non-Hodgkin lymphoma.